Table 2. Relationships of FGF19 and FGF21 with clinical, anthropometric and biochemical parameters calculated in a combined population of healthy pregnant controls and patients with GDM (n = 90).

	Serum FGF19		Serum FGF21
	r	P	r	P
Age (years)	−0.072	0.498	0.011	0.921
Gestational age at OGTT (weeks)	−0.056	0.599	−0.007	0.945
Body mass index before pregnancy (kg/m2)	−0.157	0.138	0.206	0.052
Systolic blood pressure (mm Hg)	−0.165	0.120	0.192	0.070
Diastolic blood pressure (mm Hg)	−0.021	0.844	0.158	0.138
Glucose 0 h (mmol/L)	−0.383	<0.001*	0.274	0.009*
Glucose 1 h (mmol/L)	−0.242	0.022*	0.190	0.073
Glucose 2 h (mmol/L)	−0.201	0.054	0.184	0.082
Fasting insulin (µU/ml)	−0.351	<0.001*	0.259	0.014*
HOMA-IR	−0.413	<0.001*	0.289	0.006*
Creatinine (µmol/L)	0.041	0.661	0.132	0.144
Triglycerides (mmol/L)	−0.227	0.031*	0.395	<0.001*
Total cholesterol (mmol/L)	0.095	0.373	−0.108	0.313
HDL cholesterol (mmol/L)	0.096	0.367	−0.063	0.555
LDL cholesterol (mmol/L)	0.050	0.642	−0.010	0.926
Adiponectin (µg/ml)	0.431	<0.001*	−0.377	<0.001*

The correlations were calculated in the combined population of GDM patients and controls. Units and abbreviations are as Table 1.

*Significant correlation as assessed by Spearman correlation method.